Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

https://www.thelancet.com/collections/obstetrics-gynaecology?dgcid=hubspot_email_infocusalerts-obgyn_feature&parent=001603&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-obgyn&utm_medium=email&_hsenc=p2ANqtz-9PXl-wAwXKW5ikuh_jGN5lCTPDjTtOWqhKDf44PEkmSoierJfWzAhTYO8yr-CnhKECPBZpyxuAzncIqgxGpLFVVu46IQ&_hsmi=329791076&utm_content=329568312&utm_source=hs_email